News

Newsletter

Lexology GTDT – Designs 2024

The chapter “Designs,” authored by our partners Viviane Trojan, Tarso Mesquita Machado, Fábio Ferreira, and specialist Felipe Florentino Lisboa, has been published in Lexology’s special guide, Getting The Deal Through.

The content covers a vast amount of legislative material regarding the industrial design sector in Brazil. It encompasses the related legal framework, rules for registered and unregistered design use, procedures and law enforcement, ownership changes, rights transfers, and updates and trends in the field.

On their website, you can find laws and regulations from countries around the globe, ensuring equal and open availability for all. Kasznar Leonardos serves as one of the main representatives in Brazil in this global dissemination effort for knowledge.

Read the full chapter here.

Back

Last related news

9 de December de 2025

Fake Software Resellers: A Growing Risk for Users and a New Front in IP Enforcement

For years, the most common form of software piracy involved downloading cracked or unauthorized versions from websites offering them for free. Although Fake Software Resellers: A Growing Risk for Users and a New Front in IP Enforcement

  • Kasznar Leonardos
  • Ler notícia

    25 de November de 2025

    Significant Win for Kasznar Leonardos as Appellate Court Raises Compensation in Software Infringement Case

    Kasznar Leonardos is pleased to announce an important victory before the São Paulo Court of Appeals in a software license compliance action Significant Win for Kasznar Leonardos as Appellate Court Raises Compensation in Software Infringement Case

  • Kasznar Leonardos
  • Ler notícia

    13 de November de 2025

    ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products

    The National Health Surveillance Agency (Anvisa) published on Monday, November 10, 2025, the Collegiate Board Resolution (RDC) No. 997/2025, which institutes exceptional ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products

  • Kasznar Leonardos
  • Ler notícia